PHARMAC have announced CGM funding for people with Type 1 diabetes from 1 October 2024.
Learn more - Pharmac announcement
You have nothing in your cart.
If you know the product code enter it here
If you know the product code enter it into the search field
PE/Cy7 anti-human CD303 (BDCA-2), 25 tests
PE/Cy7 anti-human CD304 (Neuropilin-1), 100 tests
PE/Cy7 anti-human CD304 (Neuropilin-1), 25 tests
PE/Cy7 anti-human CD307d (FcRL4), 100 tests
PE/Cy7 anti-human CD309 (VEGFR2), 100 tests
PE/Cy7 anti-human CD309 (VEGFR2), 25 tests
PE/Cy7 anti-human CD31, 100 tests
PE/Cy7 anti-human CD31, 25 tests
PE/Cy7 anti-human CD314 (NKG2D), 100 tests
PE/Cy7 anti-human CD314 (NKG2D), 25 tests
PE/Cy7 anti-human CD318 (CDCP1), 100 tests
PE/Cy7 anti-human CD318 (CDCP1), 25 tests
PE/Cy7 anti-human CD319 (CRACC), 100 tests
PE/Cy7 anti-human CD319 (CRACC), 25 tests
PE/Cy7 anti-human CD32, 100 tests
PE/Cy7 anti-human CD32, 25 tests